The natural cytotoxicity receptors NKp30, NKp44, and NKp46 were identified as activating receptors mainly expressed by natural killer (NK) lymphocytes. In this study we show that peripheral blood malignant CD4 T lymphocytes from patients with Sézary syndrome, an aggressive form of cutaneous T-cell lymphoma, express NKp46 at their cell surface. Although NKp46 does not behave as an independent functional receptor, its engagement provides a strong inhibiting signal on the malignant T lymphocyte CD3-induced proliferation. We show that this inhibition is correlated with a decreased phosphorylation of the CD3 chain associated with NKp46 and/or the TCR/CD3 complexes. Our results reveal that in addition to KIR3DL2/CD158k expression, NKp46 could represent an additional marker on the circulating malignant T lymphocytes of Sézary patients, where it displays an as yet unreported function of inhibitory co-receptor able to interfere with the processes governing their CD3-dependent proliferation. © 2011 The Society for Investigative Dermatology.
CITATION STYLE
Bensussan, A., Remtoula, N., Sivori, S., Bagot, M., Moretta, A., & Marie-Cardine, A. (2011). Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4 T lymphocytes of sézary syndrome patients. Journal of Investigative Dermatology, 131(4), 969–976. https://doi.org/10.1038/jid.2010.404
Mendeley helps you to discover research relevant for your work.